0001209191-23-009182.txt : 20230214
0001209191-23-009182.hdr.sgml : 20230214
20230214165314
ACCESSION NUMBER: 0001209191-23-009182
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23630963
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-10
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2023-02-10
4
F
0
3372
294.33
D
92880
D
Common Stock
2023-02-13
4
F
0
5990
298.26
D
86890
D
Common Stock
2023-02-13
4
S
0
245
296.44
D
86645
D
Common Stock
2023-02-13
4
S
0
2028
298.42
D
84617
D
Common Stock
2023-02-13
4
S
0
1779
299.26
D
82838
D
Common Stock
2023-02-13
4
S
0
835
300.13
D
82003
D
Common Stock
140
I
401(k)
Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $296.44 (range $295.84 to $296.57).
Open market sales reported on this line occurred at a weighted average price of $298.42 (range $297.85 to $298.80).
Open market sales reported on this line occurred at a weighted average price of $299.26 (range $298.86 to $299.81).
Open market sales reported on this line occurred at a weighted average price of $300.13 (range $299.93 to $300.53).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-02-14